Importance of Testing for CKD Among Patients With Type 2 Diabetes

Published: 05 Jul 2024

  • Views:

    Views Icon 557
  • Likes:

    Heart Icon 1
Average (ratings)
No ratings
Your rating

RP-UN-CAR-GB-0166 / June 2024


This programme features a compelling discussion between two distinguished experts, Prof Pam Taub (University of California, San Diego, US) and Prof Nikolaus Marx (University Hospital RWTH, Aachen, DE), chairperson responsible for the most recent ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. Together, they delve into a critical aspect of healthcare, namely type 2 diabetes and its profound link to chronic kidney disease and cardiovascular disease.

During this engaging conversation, Prof Taub and Prof Marx highlight the pivotal role that cardiologists play in diagnosing and managing kidney disease in T2D patients, given the intricate interplay between heart and kidney health within this demographic. They will explore current gaps in diagnosis, shed light on what should be happening to improve diagnosis rates, and emphasise the paramount importance of early CKD detection. The discussion will also tackle the challenges faced by clinicians in integrating essential tests such as Urine Albumin-to-Creatinine Ratio (UACR) and estimated Glomerular Filtration Rate (eGFR) into their practice.

Drawing from their expertise and professional experiences, Prof Taub and Prof Marx illustrate how early CKD diagnosis positively impacts CVD patients and their treatment journeys.


This programme has been developed and funded by Bayer. The views expressed by the HCPs in this video are their own.


You must be to comment. If you are not registered, you can register here.
Brian Clarke
Muhammad Sial
Excellent talk